Ann: Prospectus, page-3

Be nice if the directors put on a condom before fu@$in& SH's again. The greed is breathtaking, and although all of these cleansing offers, options offers, capital raisings, performance rights issues, and dilutions in the form of handouts they have/will continue to engage in, it is not with the agreement of SH's, or at least not the majority. It is the minority that have granted themselves a majority of shares, such to silence the retail shareholder, and let directors and others with their snout in the trough of CPH, continue to grow fat from the meagre supply deals they have crested to date, the ever present promise of much bigger things to come in the future, and the always imminient threat of more dilution due to CR's.

2. The Company has also agreed, subject to obtaining Shareholder approval, to issue
2,000,000 Shares to EverBlu Capital for each of the six-month periods ending
December 2020 and June 2021 subject to EverBlu Capital remaining engaged to provide
services to the Company (up to a maximum of a further 2,000,000 Shares) in accordance
with the terms of the new corporate advisory mandate announced on 21 January 2020.
3. The Company obtained Shareholder approval at the General Meeting to undertake a
placement of up to $6,000,000 worth of Shares (Future Placement). The issue price of the
Shares in respect of the Future Placement, if conducted, will be no less than 75% of the 15-
day VWAP calculated over the 15 trading days on which trades in Shares were recorded
immediately before the date on which the issue price is agreed by the Company and the
recipients of the relevant Shares. This approval will lapse on 23 March 2021.
4. The Company has also obtained Shareholder approval to issue EverBlu Capital up to
4,000,000 Shares in part consideration for services to be provided in connection with the
Future Placement (being two Shares for every three dollars raised under the Future
Placement). This approval will lapse on 23 January 2021.